Abstract
Cancer is one of the notable causes of death universally due to the emergence of therapy resistance despite the evolution of encouraging therapeutic blueprints. Increased levels of reactive oxygen species (ROS) and antioxidant defense systems leading to alteration of the redox balancing are the typical sources for cancer initiation, progression, and therapy resistance. The elevated ROS levels in cancer and therapy-resistant cells are due to the dysfunction of mitochondria and alteration of metabolism in the cancer cells. The oxidative stress induced by ROS has a dichotomous role in the regulation of cancer and therapy resistance; it may augment cancer progression leading to the therapy resistance or may facilitate cancer cell death depending upon the intensity and the extent of exposure of ROS. So, strategies have been employed either to inhibit or to increase ROS along with the manipulation of the antioxidant defense systems for sensitizing and killing the cancer cells. In this chapter, we have discussed the current understanding of the role of ROS in cancer and therapy resistance, and precisely, the sources, activation, and regulation of ROS, the dichotomous role of ROS in cancer progression and inhibition, and the molecular mechanisms involved in the ROS-mediated cancer therapy resistance.
Abbreviations
- 3-MA:
-
3-Methyladenine
- 8-OG:
-
8-Oxoguanine
- 8OHG:
-
8-Hydroxyguanine
- ABC:
-
ATP-binding cassette
- AKR:
-
Aldo-ketoreductases
- Akt:
-
Protein kinase B
- AMPK:
-
AMP-activated protein kinase
- ARE:
-
Antioxidant responsive element
- ARF:
-
Alternative reading frame
- ATM:
-
Ataxia-telangiectasia mutated
- ATP:
-
Adenosine triphosphate
- ATR:
-
ATM and Rad3-related
- BRCA1:
-
Breast Cancer gene 1
- Cdk:
-
Cyclin-dependent kinase
- Chk:
-
Checkpoint kinase
- COX2:
-
Cyclo-oxygenase 2
- CXCL14:
-
C-X-C motif chemokine 14
- Cyt-c:
-
Cytochrome- c
- DDH:
-
Dihydrodiol dehydrogenase
- DDR:
-
DNA damage response
- DNA:
-
Deoxyribonucleicacid
- DNMT1:
-
DNA methyltransferase 1
- dNTP:
-
Deoxyribonucleotide triphosphate
- DSB:
-
Double-strand break
- EMT:
-
Epithelial to mesenchymal transition
- ERK:
-
Extracellular signal-regulated kinase
- ETC:
-
Electron transport chain
- FADH2:
-
Flavin adenine Dinucleotide
- FAK:
-
Focal adhesion kinase
- FAO:
-
Fatty acid oxidation
- FOXO:
-
Forkhead box transcription factor
- G6PD:
-
Glucose-6-phosphate dehydrogenase
- GPX:
-
Glutathione peroxidase
- GR:
-
Glutathione reductase
- GSH:
-
Reduced Glutathione
- GSSG:
-
Oxidized Glutathione
- HIF1α:
-
Hypoxia-inducible factor 1α
- HMGB1:
-
High-mobility group box 1
- I-CAM:
-
Intercellular adhesion molecule 1
- IL:
-
Interleukin
- LC3:
-
Microtubule-associated protein 1A/1B-light chain 3
- LDHA:
-
Lactate dehydrogenase A
- LKB1:
-
Liver kinase B 1
- MAPK:
-
Mitogen-activated protein kinase
- MDR1:
-
Multidrug resistance 1
- MEF:
-
Mouse embryonic fibroblasts
- MIF:
-
Migration inhibitory factor
- MMP:
-
Matrix metalloproteinases
- MNC:
-
Multinucleated cells
- MSH1:
-
MutS protein homolog 1
- NADP:
-
Nicotinamide adenine dinucleotide phosphate
- NADPH:
-
Nicotinamide adenine dinucleotide phosphate reduced
- NF-kB:
-
Nuclear factor- kB
- NRF2:
-
Nuclear factor erythroid 2-related factor 2
- OGG1:
-
8-Oxoguanine DNA glycosylase 1
- PAH:
-
Polycyclic aromatic hydrocarbon
- PDGF:
-
Platelet-derived growth factor
- P-gp:
-
P-glycoprotein
- PI3K:
-
Phosphoinositide 3-kinase
- PINK1:
-
PTEN-induced kinase 1
- PPP:
-
Pentose phosphate pathway
- PRX:
-
Peroxiredoxins
- Rac1:
-
Ras-related C3 botulinum toxin substrate 1
- ROS:
-
Reactive oxygen species
- RUNX3:
-
Runt-related transcription factor 3
- SOD:
-
Superoxide dismutase
- Src:
-
Proto-oncogene c-Src
- TNF:
-
Tumor necrosis factor
- Trx:
-
Thioredoxins
- VDAC:
-
Voltage-dependent anion-selective channel
- VEGF:
-
Vascular-endothelial growth factor
References
Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Khan MA, Sethi G (2019) Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements. Biomolecules 9(11):735
Ben-Porath I, Weinberg RA (2005) The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37(5):961–976
Cadet J, Delatour T, Douki T, Gasparutto D, Pouget JP, Ravanat JL, Sauvaigo S (1999) Hydroxyl radicals and DNA base damage. Mutat Res 424(1–2):9–21
Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8(9):729–740
Carew JS, Kelly KR, Nawrocki ST (2012) Autophagy as a target for cancer therapy: new developments. Cancer Manag Res 4:357–365
Carracedo A, Cantley LC, Pandolfi PP (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13(4):227–232
Chen J, Adikari M, Pallai R, Parekh HK, Simpkins H (2008) Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 61(6):979–987
Chiarugi P, Fiaschi T (2007) Redox signalling in anchorage-dependent cell growth. Cell Signal 19(4):672–682
Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341(Pt 2):233–249
Damia G, Garattini S (2014) The pharmacological point of view of resistance to therapy in tumors. Cancer Treat Rev 40(8):909–916
Das CK, Linder B, Bonn F, Rothweiler F, Dikic I, Michaelis M, Cinatl J, Mandal M, Kogel D (2018a) BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells. Neoplasia 20(3):263–279
Das CK, Mandal M, Kogel D (2018b) Pro-survival autophagy and cancer cell resistance to therapy. Cancer Metastasis Rev 37(4):749–766
Das CK, Banerjee I, Mandal M (2020) Pro-survival autophagy: an emerging candidate of tumor progression through maintaining hallmarks of cancer. Semin Cancer Biol 66:59–74
Das CK, Parekh A, Parida PK, Bhutia SK, Mandal M (2019) Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer. Biochim Biophys Acta, Mol Cell Res 1866(6):1004–1018
Deng L, Tatebe S, Lin-Lee YC, Ishikawa T, Kuo MT (2002) MDR and MRP gene families as cellular determinant factors for resistance to clinical anticancer agents. Cancer Treat Res 112:49–66
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780–783
Dinkova-Kostova AT, Holtzclaw WD, Wakabayashi N (2005) Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 44(18):6889–6899
Dixon SJ, Stockwell BR (2014) The role of iron and reactive oxygen species in cell death. Nat Chem Biol 10(1):9–17
Durackova Z (2010) Some current insights into oxidative stress. Physiol Res 59(4):459–469
Galadari S, Rahman A, Pallichankandy S, Thayyullathil F (2015) Tumor suppressive functions of ceramide: evidence and mechanisms. Apoptosis 20(5):689–711
Gamou S, Shimizu N (1995) Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor. FEBS Lett 357(2):161–164
Gianni D, Bohl B, Courtneidge SA, Bokoch GM (2008) The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1. Mol Biol Cell 19(7):2984–2994
Gilmore AP (2005) Anoikis. Cell Death Differ 12(Suppl 2):1473–1477
Gorlach A, Bertram K, Hudecova S, Krizanova O (2015) Calcium and ROS: a mutual interplay. Redox Biol 6:260–271
Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2(1):48–58
Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM, Karantza V, Coller HA, Dipaola RS, Gelinas C, Rabinowitz JD, White E (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25(5):460–470
Hahm ER, Sakao K, Singh SV (2014) Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. Prostate 74(12):1209–1221
Huot J, Houle F, Marceau F, Landry J (1997) Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80(3):383–392
Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H (2011) CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19(3):387–400
Iverson SL, Orrenius S (2004) The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 423(1):37–46
Jeon SM, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485(7400):661–665
Kang KA, Zhang R, Kim GY, Bae SC, Hyun JW (2012) Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumour Biol 33(2):403–412
Kim EJ, Kim N, Cho SG (2013) The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp Mol Med 45:e2
Kim J, Kim J, Bae JS (2016) ROS homeostasis and metabolism: a critical liaison for cancer therapy. Exp Mol Med 48(11):e269
Kim B, Jung JW, Jung J, Han Y, Suh DH, Kim HS, Dhanasekaran DN, Song YS (2017) PGC1alpha induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells. Oncotarget 8(36):60299–60311
Kumari S, Badana AK, Murali Mohan G, Shailender G, Malla R (2018) Reactive oxygen species: a key constituent in cancer survival. Biomark Insights 13:1177271918755391
Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 107(5):2037–2042
Li J, Csibi A, Yang S, Hoffman GR, Li C, Zhang E, Yu JJ, Blenis J (2015) Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells. Proc Natl Acad Sci USA 112(1):E21–E29
Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41(3):211–218
Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135(6):2128–2140. 2140 e2121–2128
Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X, Fang J, Jiang BH (2006) Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 41(10):1521–1533
Lock R, Roy S, Kenific CM, Su JS, Salas E, Ronen SM, Debnath J (2011) Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell 22(2):165–178
Luanpitpong S, Chanvorachote P, Stehlik C, Tse W, Callery PS, Wang L, Rojanasakul Y (2013) Regulation of apoptosis by Bcl-2 cysteine oxidation in human lung epithelial cells. Mol Biol Cell 24(6):858–869
Mahjabeen I, Masood N, Baig RM, Sabir M, Inayat U, Malik FA, Kayani MA (2012) Novel mutations of OGG1 base excision repair pathway gene in laryngeal cancer patients. Familial Cancer 11(4):587–593
Maya-Mendoza A, Ostrakova J, Kosar M, Hall A, Duskova P, Mistrik M, Merchut-Maya JM, Hodny Z, Bartkova J, Christensen C, Bartek J (2015) Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress. Mol Oncol 9(3):601–616
Milligan SA, Owens MW, Grisham MB (1996) Augmentation of cytokine-induced nitric oxide synthesis by hydrogen peroxide. Am J Phys 271(1 Pt 1):L114–L120
Nguyen T, Sherratt PJ, Pickett CB (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43:233–260
Nogueira V, Hay N (2013) Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res 19(16):4309–4314
Okon IS, Zou MH (2015) Mitochondrial ROS and cancer drug resistance: implications for therapy. Pharmacol Res 100:170–174
Parekh A, Das S, Parida S, Das CK, Dutta D, Mallick SK, Wu PH, Kumar BNP, Bharti R, Dey G, Banerjee K, Rajput S, Bharadwaj D, Pal I, Dey KK, Rajesh Y, Jena BC, Biswas A, Banik P, Pradhan AK, Das SK, Das AK, Dhara S, Fisher PB, Wirtz D, Mills GB, Mandal M (2018) Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo. Oncogene 37(33):4546–4561
Pelicano H, Lu W, Zhou Y, Zhang W, Chen Z, Hu Y, Huang P (2009) Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res 69(6):2375–2383
Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M (2011) Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta 1807(6):726–734
Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M (2015) Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol 4:184–192
Quinlan CL, Perevoshchikova IV, Hey-Mogensen M, Orr AL, Brand MD (2013) Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol 1:304–312
Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436(7047):123–127
Ray PD, Huang BW, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24(5):981–990
Robinett ZN, Bathla G, Wu A, Clark JJ, Sibenaller ZA, Wilson T, Kirby P, Allen BG, Hansen MR (2018) Persistent oxidative stress in vestibular schwannomas after stereotactic radiation therapy. Otol Neurotol 39(9):1184–1190
Roebuck KA (1999) Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (review). Int J Mol Med 4(3):223–230
Safa AR (2012) c-FLIP, a master anti-apoptotic regulator. Exp Oncol 34(3):176–184
Sallmyr A, Fan J, Rassool FV (2008) Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Cancer Lett 270(1):1–9
Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30(11):1191–1212
Schrader M, Fahimi HD (2006) Peroxisomes and oxidative stress. Biochim Biophys Acta 1763(12):1755–1766
Seebacher NA, Richardson DR, Jansson PJ (2015) Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics. Br J Pharmacol 172(10):2557–2572
Shokolenko I, Venediktova N, Bochkareva A, Wilson GL, Alexeyev MF (2009) Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res 37(8):2539–2548
Shukla LI, Adhikary A, Pazdro R, Becker D, Sevilla MD (2004) Formation of 8-oxo-7,8-dihydroguanine-radicals in gamma-irradiated DNA by multiple one-electron oxidations. Nucleic Acids Res 32(22):6565–6574
Tobar N, Caceres M, Santibanez JF, Smith PC, Martinez J (2008) RAC1 activity and intracellular ROS modulate the migratory potential of MCF-7 cells through a NADPH oxidase and NFkappaB-dependent mechanism. Cancer Lett 267(1):125–132
Toyokuni S (2008) Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics. IUBMB Life 60(7):441–447
Tsai IC, Pan ZC, Cheng HP, Liu CH, Lin BT, Jiang MJ (2016) Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence. J Mol Cell Cardiol 98:18–27
Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266(1):37–52
Wang J, Li XM, Bai Z, Chi BX, Wei Y, Chen X (2018) Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3beta/cyclin D1 pathway. J Ethnopharmacol 210:1–9
Wu Q, Ni X (2015) ROS-mediated DNA methylation pattern alterations in carcinogenesis. Curr Drug Targets 16(1):13–19
Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, Liang X (2018) The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 37(1):266
Yang Y, Ishak Gabra MB, Hanse EA, Lowman XH, Tran TQ, Li H, Milman N, Liu J, Reid MA, Locasale JW, Gil Z, Kong M (2019) MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1. Nat Commun 10(1):809
Yin L, Kufe T, Avigan D, Kufe D (2014) Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death. Blood 123(19):2997–3006
Zhang H, Liu H, Davies KJ, Sioutas C, Finch CE, Morgan TE, Forman HJ (2012) Nrf2-regulated phase II enzymes are induced by chronic ambient nanoparticle exposure in young mice with age-related impairments. Free Radic Biol Med 52(9):2038–2046
Zhang R, Kang KA, Kim KC, Na SY, Chang WY, Kim GY, Kim HS, Hyun JW (2013) Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells. Gene 524(2):214–219
Zhao C, He R, Shen M, Zhu F, Wang M, Liu Y, Chen H, Li X, Qin R (2019) PINK1/Parkin-mediated mitophagy regulation by reactive oxygen species alleviates rocaglamide A-induced apoptosis in pancreatic cancer cells. Front Pharmacol 10:968
Zong WX, Thompson CB (2006) Necrotic death as a cell fate. Genes Dev 20(1):1–15
Acknowledgment
We would like to acknowledge Department of Science and Technology (DST-INSPIRE-IF130677), University Grants Commission (UGC), Council of Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR), Science and Engineering Research Board (SERB-J C Bose National Fellowship), Ministry of Human Resource and Development (MHRD), Government of India; Indian Institute of Technology Kharagpur, India; and German Academic Exchange Service (DAAD), Germany, for providing financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Das, C.K., Majumder, R., Roy, P., Mandal, M. (2021). The Intricacy of ROS in Cancer Therapy Resistance. In: Chakraborti, S., Ray, B.K., Roychowdhury, S. (eds) Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-15-4501-6_125-1
Download citation
DOI: https://doi.org/10.1007/978-981-15-4501-6_125-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4501-6
Online ISBN: 978-981-15-4501-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences